MCHPP vs TXN
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 09, 2026
MCHPP
57.8
AI Score
VS
TXN Wins
TXN
66.9
AI Score
Investment Advisor Scores
TXN
67score
Recommendation
BUY
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | MCHPP | TXN | Winner |
|---|---|---|---|
| Revenue | 1.48B | 10.29B | TXN |
| Net Income | 229.80M | 3.52B | TXN |
| Gross Margin | 63.2% | 59.8% | MCHPP |
| Net Margin | 15.5% | 34.3% | TXN |
| Operating Income | 336.80M | 4.12B | TXN |
| ROE | 3.6% | 19.6% | TXN |
| ROA | 1.6% | 9.8% | TXN |
| Total Assets | 14.41B | 35.88B | TXN |
| Cash | 272.30M | 3.66B | TXN |
| Debt/Equity | 0.83 | 0.78 | TXN |
| Current Ratio | 1.92 | 4.86 | TXN |
| Free Cash Flow | 497.60M | 3.03B | TXN |
Relative Price Performance (Last 90 Days)
MCHPP 1M: -6.5%
· 3M: -18.7%
TXN 1M: -2.9%
· 3M: -9.6%
Current Technical Phase
MCHPP
NeutralHold
Mixed signals - no dominant trend phase, RSI 45
TXN
NeutralHold
Mixed signals - no dominant trend phase, RSI 52
Fundamentals Snapshot
| Metric | MCHPP | TXN |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 0.0 | 26.6 |
| Trailing P/E | — | 39.7 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.4% | 0.2% |
| Gross Margin | 0.6% | 0.6% |
| Operating Margin | 0.2% | 0.4% |
| EPS | 0.00 | 6.52 |
| Dividend Yield | 0.03% | 0.02% |
Frequently Asked Questions
Based on our detailed analysis, TXN is currently the stronger investment candidate, winning 11 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.